Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Income from Non-Controlling Interests (2020 - 2026)

Nutex Health (NUTX) has disclosed Income from Non-Controlling Interests for 7 consecutive years, with $16.0 million as the latest value for Q1 2026.

  • For Q1 2026, Income from Non-Controlling Interests fell 46.07% year-over-year to $16.0 million; the TTM value through Mar 2026 reached $95.9 million, up 31.67%, while the annual FY2025 figure was $109.6 million, 156.55% up from the prior year.
  • Income from Non-Controlling Interests hit $16.0 million in Q1 2026 for Nutex Health, up from $4.8 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $41.4 million in Q3 2025 and bottomed at -$10.7 million in Q3 2022.
  • Average Income from Non-Controlling Interests over 5 years is $9.1 million, with a median of $3.4 million recorded in 2024.
  • Year-over-year, Income from Non-Controlling Interests tumbled 11808.0% in 2022 and then surged 16723.03% in 2025.
  • Nutex Health's Income from Non-Controlling Interests stood at $4.1 million in 2022, then dropped by 4.57% to $3.9 million in 2023, then surged by 879.73% to $38.3 million in 2024, then crashed by 87.53% to $4.8 million in 2025, then surged by 234.23% to $16.0 million in 2026.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at $16.0 million, $4.8 million, and $41.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.